Discover 1,057 paid clinical trials in Alabama. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Alabama provides a diverse range of research opportunities for healthy volunteers and individuals with specific health conditions. Leading research centers in Birmingham, Montgomery, and Mobile are seeking participants, offering access to innovative treatments and cutting-edge medical care.
Filter
1
Filter results
Results: 1,057
Featured
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: Richmond VA, West Palm Beach FL, Miami FL,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
Responding With Evidence and Access for Childhood Headaches
Location: Philadelphia PA, Wilmington DE, Amherst NY,
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 10 - 17
Code: NCT05889624
Recruiting
Active & Responsive
A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome
for
Rett Syndrome
Location: Boston MA, New York NY, Baltimore MD, Chapel Hill NC,
Sponsor: Neurogene Inc.
Sex: Female
Age: 3+
Code: NCT05898620
Phase3, Recruiting
Active & Responsive
Study of GS-0151 in Participants With Rheumatoid Arthritis
for
Rheumatoid Arthritis
Location: Virginia Beach VA, Duncansville PA, Clearwater FL,
Sponsor: Gilead Sciences
Sex: All
Age: 18 - 70+
Code: NCT06902519
Phase1, Recruiting
Active & Responsive
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
for
Platinum-resistant Ovarian Cancer,
Location: Stony Brook NY, Greenville NC, Silver Spring MD,
Sponsor: Genelux Corporation
Sex: Female
Age: 18+
Code: NCT05281471
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies